Other antibiotic groups did not reach statistical significance in the risk factor analysis, yet the numbers of travellers using each individual antibiotic type were small; eight had taken beta-lactams (ESBL-PE(+) 50.0%; AOR 3.4, CI 0.5–21.9) and 14 other antimicrobials (ESBL-PE(+) 35.7%; AOR 3.8 CI 0.9–14.6).
← all excerpts
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
1
—
—